Galapagos dosed the first cystic fibrosis (CF) patient with GLPG2222, its novel CF corrector, in a Phase 2a…
Articles by Patrícia Silva, PhD
The U.S. Food and Drug Administration (FDA) has designated Concert Pharmaceuticals‘ next-generation therapy, CTP-656, an Orphan Drug to treat…
The Cystic Fibrosis Foundation has announced the recipients of its first Impact Grants, which support individuals or organizations that positively…
The first patients have been dosed in the Phase 2 clinical trial evaluating NovaBiotics‘ Lynovex (NM001, cysteamine) as…
First Allied Securities has given the Cystic Fibrosis Foundation a $73,487 donation for research and programs dealing with the disease. Archie…
Cystic Fibrosis Foundation Therapeutics (CFFT), the drug discovery arm of the Cystic Fibrosis Foundation (CFF), has awarded Aridis…
Hubrecht Organoid Technology (HUB) and the Dutch health insurance companies CZ, Zilveren Kruis and Menzis plan to launch a €3…
Researchers at the University of Limerick, in Ireland, have developed a disposable percussion device, called SoloPEP, that works to…
A research team at Northwestern University has developed a flexible and wearable electronic device, which adheres to the skin, to measure…
Scientists at the University of Queensland, Australia, are focusing their efforts on what is one of world’s leading sources of antibiotic…